Physician profile
Sandra R Kuefner
NPI 1699035956
$1,128.27
in general payments reported to CMS, 2019-2025
8 companies · $160 in 2025
The $160 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $40.74 · 2022: $305 · 2023: $345 · 2024: $278 · 2025: $160.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $783.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $782.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $246.04 | 2022 | |
| Merck Sharp & Dohme LLC | $212.56 | 2021-2025 | Bridion |
| Relievant Medsystems, INC. | $155.12 | 2023 | Intracept |
| Medtronic, INC. | $136.13 | 2024 | Synchromedii |
| Averitas Pharma INC. | $124.99 | 2023 | Qutenza |
| Vertex Pharmaceuticals Incorporated | $118.72 | 2025 | |
| Braeburn INC. | $104.59 | 2024 | Brixadi |
| Cumberland Pharmaceuticals, INC. | $30.12 | 2023 | Caldolor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Kuefner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.